{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:27:14Z","timestamp":1790072834828,"version":"4.0.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,14]],"date-time":"2014-11-14T00:00:00Z","timestamp":1415923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2014,11,14]],"date-time":"2014-11-14T00:00:00Z","timestamp":1415923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A high proportion of patients with stable angina remains symptomatic despite multiple treatment options. Di'ao Xinxuekang (XXK) capsule and Compound Danshen (CDS) tablet have been approved for treating angina pectoris for more than 20 years in China. We compare the anti-anginal effectiveness of XXK capsule and CDS tablet in patients with symptomatic chronic stable angina. A randomized, multicenter, double-blind, parallel-group, superiority trial was conducted in 4 study sites. 733 patients with symptomatic chronic stable angina were included in the full analysis set. The primary outcomes were the proportion of patients who were angina-free and the proportion of patients with normal electrocardiogram (ECG) recordings during 20 weeks treatment. Compared with CDS, XXK significantly increased the proportion of angina-free patients, but no significant difference was noted in the proportion of patients with normal ECG recordings. Weekly angina frequency and nitroglycerin use were significantly reduced with XXK versus CDS at week 20. Moreover, XXK also improved the quality of life of angina patients as measured by the SAQ score and <jats:italic>Xueyu Zheng<\/jats:italic> (a type of TCM syndrome) score. We demonstrate that XXK capsule is more effective for attenuating anginal symptoms and improving quality of life in patients with symptomatic chronic stable angina, compared with CDS tablet.<\/jats:p>","DOI":"10.1038\/srep07058","type":"journal-article","created":{"date-parts":[[2014,11,14]],"date-time":"2014-11-14T10:14:26Z","timestamp":1415960066000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Comparative Effectiveness of Di'ao Xin Xue Kang Capsule and Compound Danshen Tablet in Patients With Symptomatic Chronic Stable Angina"],"prefix":"10.1038","volume":"4","author":[{"given":"Yanan","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shurong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songshan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiguang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunti","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,14]]},"reference":[{"key":"BFsrep07058_CR1","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1161\/CIRCULATIONAHA.109.192703","volume":"121","author":"DM Lloyd-Jones","year":"2010","unstructured":"Lloyd-Jones, D. M. et al. Defining and setting national goals for cardio vascular health promotion and disease reduction: The American Heart Association's strategic impact goal through 2020 and beyond. Circulation 121, 586\u2013613 (2010).","journal-title":"Circulation"},{"key":"BFsrep07058_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.7861\/clinmedicine.13-1-63","volume":"13","author":"JM Tarkin","year":"2013","unstructured":"Tarkin, J. M. & Kaski, J. C. Pharmacological treatment of chronic stable angina pectoris. Clin Med 13, 63\u201370 (2013).","journal-title":"Clin Med"},{"key":"BFsrep07058_CR3","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1016\/S0735-1097(99)00150-3","volume":"133","author":"RJ Gibbons","year":"1999","unstructured":"Gibbons, R. J. et al. ACC\/AHA\/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 133, 2092\u20132197 (1999).","journal-title":"J Am Coll Cardiol"},{"key":"BFsrep07058_CR4","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1177\/107424840400900103","volume":"9","author":"U Thadani","year":"2004","unstructured":"Thadani, U. Current medical management of chronic stable angina. J Cardiovasc Pharmacol Ther 9, S11\u201329 (2004).","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"BFsrep07058_CR5","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.amjmed.2004.02.044","volume":"117","author":"FC Wiest","year":"2004","unstructured":"Wiest, F. C. et al. Suboptimal pharmacotherapeutic management of chronic stable angina in the primary care setting. Am J Med 117, 234\u2013241 (2004).","journal-title":"Am J Med"},{"key":"BFsrep07058_CR6","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ijcard.2003.10.050","volume":"98","author":"BA Kirwan","year":"2005","unstructured":"Kirwan, B. A., Lubsen, J. & Poole-Wilson, P. A. Treatment of angina pectoris: associations with symptom severity. Int J Cardiol 98, 299\u2013306 (2005).","journal-title":"Int J Cardiol"},{"key":"BFsrep07058_CR7","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.recesp.2012.03.011","volume":"65","author":"X Borr\u00e1s","year":"2012","unstructured":"Borr\u00e1s, X., Garcia-Moll, X., G\u00f3mez-Doblas, J. J., Zapata, A. & Artigas, R. Stable angina in Spain and its impact on quality of life. The AVANCE Registry. Rev Esp Cardiol 65, 734\u2013741 (2012).","journal-title":"Rev Esp Cardiol"},{"key":"BFsrep07058_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1161\/01.CIR.0000020688.24874.90","volume":"106","author":"JA Spertus","year":"2002","unstructured":"Spertus, J. A., Jones, P., McDonell, M., Fan, V. & Fihn, S. D. Health status predicts long-term outcome in outpatients with coronary disease. Circulation 106, 43\u201349 (2002).","journal-title":"Circulation"},{"key":"BFsrep07058_CR9","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/S0002-8703(03)00436-8","volume":"146","author":"D Mozaffarian","year":"2003","unstructured":"Mozaffarian, D., Bryson, C. L., Spertus, J. A., McDonell, M. B. & Fihn, S. D. Anginal symptoms consistently predict total mortality among outpatients with coronary artery disease. Am Heart J 146, 1015\u20131022 (2003).","journal-title":"Am Heart J"},{"key":"BFsrep07058_CR10","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1161\/CIRCULATIONAHA.109.887380","volume":"120","author":"J Berecki-Gisolf","year":"2009","unstructured":"Berecki-Gisolf, J., Humphreyes-Reid, L., Wilson, A. & Dobson, A. Angina symptoms are associated with mortality in older women with ischemic heart disease. Circulation 120, 2330\u20132336 (2009).","journal-title":"Circulation"},{"key":"BFsrep07058_CR11","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.biotechadv.2011.11.005","volume":"30","author":"FM Chen","year":"2012","unstructured":"Chen, F. M., Zhao, Y. M., Jin, Y. & Shi, S. Prospects for translational regenerative medicine. Biotechnol Adv 30, 658\u2013672 (2012).","journal-title":"Biotechnol Adv"},{"key":"BFsrep07058_CR12","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.yebeh.2005.11.015","volume":"8","author":"NJ Sucher","year":"2006","unstructured":"Sucher, N. J. Insights from molecular investigations of traditional Chinese herbal stroke medicines: implications for neuroprotective epilepsy therapy. Epilepsy Behav 8, 350\u2013362 (2006).","journal-title":"Epilepsy Behav"},{"key":"BFsrep07058_CR13","doi-asserted-by":"publisher","first-page":"234","DOI":"10.5732\/cjc.009.10598","volume":"29","author":"JJ Zhang","year":"2010","unstructured":"Zhang, J. J., Meng, Q., Chang, W. & Wan, C. H. Clinical assessment of the efficacy of anti-cancer treatment: current status and perspectives. Chin J Cancer 29, 234\u2013238 (2010).","journal-title":"Chin J Cancer"},{"key":"BFsrep07058_CR14","doi-asserted-by":"publisher","first-page":"e94466","DOI":"10.1371\/journal.pone.0094466","volume":"9","author":"J Liu","year":"2014","unstructured":"Liu, J. et al. Therapeutic Effect of Jinzhen Oral Liquid for Hand Foot and Mouth Disease: A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Trial. PLoS One 9, e94466 (2014).","journal-title":"PLoS One"},{"key":"BFsrep07058_CR15","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.jacc.2013.05.035","volume":"l6","author":"X Li","year":"2013","unstructured":"Li, X. et al. A Multicenter Randomized Double-Blind Parallel-Group Placebo-Controlled Study of the Effects of Qili Qiangxin Capsules in Patients with Chronic Heart Failure. J Am Coll Cardio l6, 1065\u20131072 (2013).","journal-title":"J Am Coll Cardio"},{"key":"BFsrep07058_CR16","first-page":"282707","volume":"2013","author":"Y Jia","year":"2013","unstructured":"Jia, Y. et al. The efficacy of guanxinning injection in treating angina pectoris: systematic review and meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. 2013, 282707 (2013).","journal-title":"Evid Based Complement Alternat Med."},{"key":"BFsrep07058_CR17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ctim.2014.01.003","volume":"22","author":"X Yang","year":"2014","unstructured":"Yang, X., Xiong, X., Yang, G. & Wang, J. Chinese patent medicine Xuefu Zhuyu capsule for the treatment of unstable angina pectoris: A systematic review of randomized controlled trials. Complement Ther Med. 22, 391\u2013399 (2014).","journal-title":"Complement Ther Med."},{"key":"BFsrep07058_CR18","unstructured":"Pharmacopoeia Commission of the People's Republic of China. Pharmacopoeia of the People's Republic of China [671\u2013672] (China Medical Science Press, Beijing, 2010)."},{"key":"BFsrep07058_CR19","first-page":"349","volume":"14","author":"SX Chen","year":"1995","unstructured":"Chen, S. X., Chen, M. F., Zheng, X. J. & Chang, P. L. Effects of Di'ao Xinxuekang on vascular function and microcirculation of nail fold in patients with coronary artery disease. Zhongguo xin yao yu lin chuang za zhi 14, 349 (1995).","journal-title":"Zhongguo xin yao yu lin chuang za zhi"},{"key":"BFsrep07058_CR20","first-page":"88","volume":"13","author":"J Liu","year":"1994","unstructured":"Liu, J., Zhen, C. Q. & Lu, Y. Effects of Di'ao Xinxuekang on microcirculation of nail fold in 64 patients with angina pectoris. Zhongguo xin yao yu lin chuang za zhi 13, 88 (1994).","journal-title":"Zhongguo xin yao yu lin chuang za zhi"},{"key":"BFsrep07058_CR21","first-page":"23","volume":"9","author":"QC Ni","year":"1997","unstructured":"Ni, Q. C., Ren, X. B. & Wang, X. D. Observation study of Di'ao Xinxuekang on erythrocyte deformability and microcirculation of nail fold in patients with coronary artery disease. Haixia yaoxue 9, 23 (1997).","journal-title":"Haixia yaoxue"},{"key":"BFsrep07058_CR22","first-page":"47","volume":"64","author":"J Qin","year":"2014","unstructured":"Qin, J. et al. Dioscin prevents the mitochondrial apoptosis and attenuates oxidative stress in cardiac H9c2 cells. Drug Res (Stuttg) 64, 47\u201352 (2014).","journal-title":"Drug Res (Stuttg)"},{"key":"BFsrep07058_CR23","first-page":"152","volume":"13","author":"ZY Feng","year":"1994","unstructured":"Feng, Z. Y. Efficacy evalution of Di'ao Xinxuekang treating participants with angina pectoris: a phase II clinical trial. Zhongguo xin yao yu lin chuang za zhi 13, 152\u2013155 (1994).","journal-title":"Zhongguo xin yao yu lin chuang za zhi"},{"key":"BFsrep07058_CR24","first-page":"309","volume":"3","author":"DJ Shen","year":"1997","unstructured":"Shen, D. J. Efficacy evalution of Di'ao Xinxuekang treating participants with ischemic heart disease. Guilin yixueyuan xuebao 3, 309\u2013310 (1997).","journal-title":"Guilin yixueyuan xuebao"},{"key":"BFsrep07058_CR25","first-page":"24","volume":"1","author":"ZH Huang","year":"2009","unstructured":"Huang, Z. H. Evaluation the efficacy of Di'ao Xinxuekang capsule treating ischemic heart disease angina pectoris. Yiyao luntan 1, 24\u201325 (2009).","journal-title":"Yiyao luntan"},{"key":"BFsrep07058_CR26","first-page":"904147","volume":"2012","author":"Y Jia","year":"2012","unstructured":"Jia, Y., Chen, C., Ng, C. S. & Leung, S. W. Meta-Analysis of Randomized Controlled Trials on the Efficacy of Di'ao Xinxuekang Capsule and Isosorbide Dinitrate in Treating Angina Pectoris. Evid Based Complement Alternat Med. 2012, 904147 (2012).","journal-title":"Evid Based Complement Alternat Med."},{"key":"BFsrep07058_CR27","unstructured":"Chinese Medicine Experts Group of European ederaion of Chinese Medicine Societies. Meta-analysis of Di'ao Xinxuekang capsule in treating ischemic heart disease. Zhongguo xiangcun yisheng 16, 15 (2010)."},{"key":"BFsrep07058_CR28","unstructured":"Pharmacopoeia Commission of the People's Republic of China. Pharmacopoeia of the People's Republic of China [904\u2013905] (China Medical Science Press, Beijing, 2010)."},{"key":"BFsrep07058_CR29","first-page":"1151","volume":"25","author":"SW Chen","year":"2004","unstructured":"Chen, S. W., Li, X. H., Ye, K. H., Jiang, Z. F. & Ren, X. D. Total saponins of Panax noto-ginseng protected rabbit iliac artery against balloon endothelial denudation injury. Acta Pharmacol sin 25, 1151\u20131156 (2004).","journal-title":"Acta Pharmacol sin"},{"key":"BFsrep07058_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ijcard.2007.01.004","volume":"121","author":"TO Cheng","year":"2007","unstructured":"Cheng, T. O. Cardiovascular effects of Danshen. Int J Cardiol 121, 9\u201322 (2007).","journal-title":"Int J Cardiol"},{"key":"BFsrep07058_CR31","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.3892\/etm.2013.1291","volume":"6","author":"CS Zheng","year":"2013","unstructured":"Zheng, C. S. et al. Computational pharmacological comparison of Salvia miltiorrhiza and Panax notoginseng used in the therapy of cardiovascular diseases. Exp Ther Med. 6, 1163\u20131168 (2013).","journal-title":"Exp Ther Med."},{"key":"BFsrep07058_CR32","first-page":"14","volume":"5","author":"BL Zhang","year":"2003","unstructured":"Zhang, B. L., Gao, X. M., Shang, H. C., Zhao, Y. J. & Wang, Y. Y. Study on Pharmaceutical Matters and Functional Mechanisms of Complex Prescriptions of Radix Salvial Milti Orrhizal. Shi jie ke xue ji shu: Zhong yi yao xian dai hua. 5, 14\u201317 (2003).","journal-title":"Shi jie ke xue ji shu: Zhong yi yao xian dai hua."},{"key":"BFsrep07058_CR33","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0002-9149(81)90391-X","volume":"47","author":"P Cohn","year":"1981","unstructured":"Cohn, P. et al. Prognostic importance of anginal symptoms in angiographically defined coronary artcty disease. Am J Cardio 47, 233\u2013237 (1981).","journal-title":"Am J Cardio"},{"key":"BFsrep07058_CR34","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1001\/archinternmed.2009.295","volume":"169","author":"JF Beltrame","year":"2009","unstructured":"Beltrame, J. F., Weekes, A. J., Morgan, C., Tavella, R. & Spertus, J. A. The prevalence of weekly angina among patients with chronic stable angina in primary care practices: The Coronary Artery Disease in General Practice (CADENCE) Study. Arch Intern Med 169, 1491\u20131499 (2009).","journal-title":"Arch Intern Med"},{"key":"BFsrep07058_CR35","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1161\/01.CIR.80.2.410","volume":"80","author":"E Braunwald","year":"1989","unstructured":"Braunwald, E. Unstable angina: a classification. Circulation 80, 410\u2013414 (1989).","journal-title":"Circulation"},{"key":"BFsrep07058_CR36","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0735-1097(95)00489-0","volume":"27","author":"S Savonitto","year":"1996","unstructured":"Savonitto, S. et al. Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris results of the international multicenter angina exercise(IMAGE) study. J Am Coll Cardiol 27, 311\u2013316 (1996).","journal-title":"J Am Coll Cardiol"},{"key":"BFsrep07058_CR37","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1093\/eurheartj\/ehi586","volume":"26","author":"JC Tardif","year":"2005","unstructured":"Tardif, J. C., Ford, I., Bourassa, M. G. & Fox, K. Efficacy of ivabradine, a new selective If inhibitor, compared with atenolol in patients with chronic stable angina. Eur Heart J. 26, 2529\u20132536 (2005).","journal-title":"Eur Heart J."},{"key":"BFsrep07058_CR38","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.jacc.2006.05.044","volume":"48","author":"PH Stone","year":"2006","unstructured":"Stone, P. H., Gratsiansky, N. A., Blokhin, A., Huang, I. Z. & Meng, L. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial. J Am Coll Cardiol 48, 566\u2013575 (2006).","journal-title":"J Am Coll Cardiol"},{"key":"BFsrep07058_CR39","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.jacc.2005.07.047","volume":"46","author":"RM Vicari","year":"2005","unstructured":"Vicari, R. M. et al. Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial. J Am Coll Cardiol 46, 1803\u20131811 (2005).","journal-title":"J Am Coll Cardiol"},{"key":"BFsrep07058_CR40","first-page":"47","volume":"64","author":"J Qin","year":"2014","unstructured":"Qin, J. et al. Dioscin prevents the mitochondrial apoptosis and attenuates oxidative stress in cardiac H9c2 cells. Drug Res (Stuttg) 64, 47\u201352 (2014).","journal-title":"Drug Res (Stuttg)"},{"key":"BFsrep07058_CR41","doi-asserted-by":"crossref","unstructured":"Ren-An, Q. et al. Study of the protective mechanisms of Compound Danshen Tablet (Fufang Danshen Pian) against myocardial ischemia\/reperfusion injury via the Akt-eNOS signaling pathway in rats. J Ethnopharmacol. 10.1016\/j.jep.2014.08.023 (2014). [Epub ahead of print].","DOI":"10.1016\/j.jep.2014.08.023"},{"key":"BFsrep07058_CR42","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jpba.2009.12.016","volume":"52","author":"Y Lv","year":"2010","unstructured":"Lv, Y. et al. Metabolomic study of myocardial ischemia and intervention effects of Compound Danshen Tablets in rats using ultra-performance liquid chromatography\/quadrupole time-of-flight mass spectrometry. J Pharm Biomed Anal 52, 129\u2013135 (2010).","journal-title":"J Pharm Biomed Anal"},{"key":"BFsrep07058_CR43","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1161\/01.CIR.88.6.2548","volume":"88","author":"JM Murabito","year":"1993","unstructured":"Murabito, J. M., Evans, J. C., Larson, M. G. & Levy, D. Prognosis after the onset of coronary heart disease: an investigation of differences in outcome between the sexes according to initial coronary disease presentation. Circulation 88, 2548\u20132555 (1993).","journal-title":"Circulation"},{"key":"BFsrep07058_CR44","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1067\/mhj.2001.119133","volume":"142","author":"DS Sheps","year":"2001","unstructured":"Sheps, D. S. et al. Sex differences in chest pain in patients with documented coronary artery disease and exercise-induced ischemia: results from the PIMI study. Am Heart J 142, 864\u2013871 (2001).","journal-title":"Am Heart J"},{"key":"BFsrep07058_CR45","first-page":"573","volume":"36","author":"XQ Liu","year":"2008","unstructured":"Liu, X. Q. The epidemiology and burden of coronary artery disease. Chin J Cardiol 36, 573\u2013575 (2008).","journal-title":"Chin J Cardiol"},{"key":"BFsrep07058_CR46","doi-asserted-by":"crossref","unstructured":"Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology\/World Health Organization task force on standardization of clinical nomenclature. Circulation 59, 607\u2013609 (1979).","DOI":"10.1161\/01.CIR.59.3.607"},{"key":"BFsrep07058_CR47","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1161\/circ.54.3.947585","volume":"54","author":"L Campeau","year":"1976","unstructured":"Campeau, L. Grading of angina pectoris. Circulation 54, 522\u201323 (1976).","journal-title":"Circulation"},{"key":"BFsrep07058_CR48","unstructured":"Zheng, X. Y. Clinical research guiding principle for new Chinese herbal medicine [68\u201373] (Chinese medical science and technology press, Beijing, (2002)."},{"key":"BFsrep07058_CR49","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/0002-9149(94)90555-X","volume":"74","author":"JA Spertus","year":"1994","unstructured":"Spertus, J. A., Winder, J. A., Dewhurst, T. A., Deyo, R. A. & Fihn, S. D. Monitoring the quality of life in patients with coronary artery disease. Am J Cardiol 74, 1240\u20131244 (1994).","journal-title":"Am J Cardiol"},{"key":"BFsrep07058_CR50","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ahj.2003.10.039","volume":"147","author":"WM Tierney","year":"2004","unstructured":"Tierney, W. M., Babu, A. N. & Wolinsky, F. D. Clinically important differences in health status for patients with heart disease: an expert consensus panel report. Am Heart J 147, 615\u2013622 (2004).","journal-title":"Am Heart J"},{"key":"BFsrep07058_CR51","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1136\/bmj.319.7211.670","volume":"319","author":"S Hollis","year":"1999","unstructured":"Hollis, S. & Campbell, F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 319, 670\u2013674 (1999).","journal-title":"BMJ"},{"key":"BFsrep07058_CR52","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1056\/NEJMsr1203730","volume":"367","author":"RJ Little","year":"2012","unstructured":"Little, R. J. et al. The Prevention and Treatment of Missing Data in Clinical Trials. N Engl J Med 367, 1355\u20131360 (2012).","journal-title":"N Engl J Med"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep07058.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep07058","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep07058.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T06:02:52Z","timestamp":1672984972000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep07058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,14]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,12,17]]}},"alternative-id":["BFsrep07058"],"URL":"https:\/\/doi.org\/10.1038\/srep07058","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,14]]},"assertion":[{"value":"18 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7058"}}